These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25072311)

  • 1. Pediatric vascularized composite allotransplantation.
    Doumit G; Gharb BB; Rampazzo A; Papay F; Siemionow MZ; Zins JE
    Ann Plast Surg; 2014 Oct; 73(4):445-50. PubMed ID: 25072311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
    Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
    Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Strategies in Transplantation: Genetic Engineering and Vascularized Composite Allotransplantation.
    Kauke-Navarro M; Noel OF; Knoedler L; Knoedler S; Panayi AC; Stoegner VA; Huelsboemer L; Pomahac B
    J Surg Res; 2023 Nov; 291():176-186. PubMed ID: 37429217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Status of Vascularized Composite Allotransplantation.
    Kaufman CL; Bhutiani N; Ramirez A; Tien HY; Palazzo MD; Galvis E; Farner S; Ozyurekoglu T; Jones CM
    Am Surg; 2019 Jun; 85(6):631-637. PubMed ID: 31267905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Significance of Vascular Alterations in Acute and Chronic Rejection for Vascularized Composite Allotransplantation.
    Kollar B; Kamat P; Klein HJ; Waldner M; Schweizer R; Plock JA
    J Vasc Res; 2019; 56(4):163-180. PubMed ID: 31266018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composite tissue allotransplantation: opportunities and challenges.
    Iske J; Nian Y; Maenosono R; Maurer M; Sauer IM; Tullius SG
    Cell Mol Immunol; 2019 Apr; 16(4):343-349. PubMed ID: 30842628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penile Allotransplantation for Complex Genitourinary Reconstruction.
    Sopko NA; Tuffaha SH; Lough D; Brandacher G; Lee WPA; Bivalacqua TJ; Redett RJ; Burnett AL
    J Urol; 2017 Aug; 198(2):274-280. PubMed ID: 28286074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Urogenital Epithelium and Corporal Tissues Are the Primary Targets of Rejection in Penile Vascularized Composite Allotransplantation: A New Real-Time Tissue-Based Monitoring System.
    Lough DM; Sopko NA; Matsui H; Miller D; Swanson EW; Bluebond-Langner R; Brandacher G; Burnett AL; Bivalacqua TJ; Redett RJ
    Plast Reconstr Surg; 2019 Mar; 143(3):534e-544e. PubMed ID: 30817651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper extremity and craniofacial vascularized composite allotransplantation: ethics and immunosuppression.
    Benedict J; Magill G
    Emerg Top Life Sci; 2019 Nov; 3(6):681-686. PubMed ID: 32915212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.
    Wang HD; Fidder SAJ; Miller DT; Furtmüller GJ; Ahmadi AR; Nägele F; Lopez J; Quan A; Budihardjo J; Lough DM; Akpinarli B; Etra JW; Vasilic D; Raimondi G; Lee WPA; Montgomery RA; Sun Z; Brandacher G
    Transplantation; 2018 Apr; 102(4):593-600. PubMed ID: 29298238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascularised composite allotransplantation in solid organ transplant recipients: A systematic review.
    Honeyman C; Stark HL; Fries CA; Gorantla VS; Davis MR; Giele H
    J Plast Reconstr Aesthet Surg; 2021 Feb; 74(2):316-326. PubMed ID: 33036926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral Alloreactivity in VCA Recipients: Should We Learn From Our Experience?
    Sicard A; Kanitakis J; Dubois V; Morelon E; Thaunat O
    Transplantation; 2020 Oct; 104(10):2003-2010. PubMed ID: 32039965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular activation pathways and interaction networks in vascularized composite allotransplantation.
    Knoedler L; Knoedler S; Panayi AC; Lee CAA; Sadigh S; Huelsboemer L; Stoegner VA; Schroeter A; Kern B; Mookerjee V; Lian CG; Tullius SG; Murphy GF; Pomahac B; Kauke-Navarro M
    Front Immunol; 2023; 14():1179355. PubMed ID: 37266446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation.
    Olariu R; Denoyelle J; Leclère FM; Dzhonova DV; Gajanayake T; Banz Y; Hayoz M; Constantinescu M; Rieben R; Vögelin E; Taddeo A
    J Surg Res; 2017 Oct; 218():49-57. PubMed ID: 28985877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
    Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
    Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascularized composite allograft-specific characteristics of immune responses.
    Issa F
    Transpl Int; 2016 Jun; 29(6):672-81. PubMed ID: 26927941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is needed to ensure long-term sustainability for the field of vascularized composite allotransplantation?
    Toyoda Y; Levin LS
    Curr Opin Organ Transplant; 2023 Dec; 28(6):446-451. PubMed ID: 37767962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
    Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
    Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.
    Radu CA; Fischer S; Diehm Y; Hetzel O; Neubrech F; Dittmar L; Kleist C; Gebhard MM; Terness P; Kneser U; Kiefer J
    Langenbecks Arch Surg; 2018 Feb; 403(1):83-92. PubMed ID: 28823033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large Animal Models of Vascularized Composite Allotransplantation: A Review of Immune Strategies to Improve Allograft Outcomes.
    Matar AJ; Crepeau RL; Mundinger GS; Cetrulo CL; Torabi R
    Front Immunol; 2021; 12():664577. PubMed ID: 34276656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.